Sundowning in dementia
Pro Research Analysisby 
Searched over 200M research papers
Sundowning in Dementia: Definition and Clinical Features
Sundowning in dementia refers to the emergence or worsening of neuropsychiatric symptoms—such as agitation, confusion, anxiety, and irritability—during the late afternoon, evening, or night. This phenomenon is common among people with dementia and is recognized by healthcare providers as a significant challenge in dementia care Canevelli2016Reimus2025Blasi2023+1 MORE. The prevalence of sundowning varies widely, with estimates ranging from 1.6% to 66% among dementia patients Reimus2025Blasi2023. The most frequently observed symptoms include agitation, irritability, and anxiety, which can cause distress for both patients and caregivers Blasi2023Khachiyants2011Nazarko2011.
Pathophysiological and Environmental Determinants of Sundowning
The causes of sundowning are complex and involve neurobiological, psychosocial, and environmental factors. Neurodegeneration, particularly in the suprachiasmatic nucleus of the hypothalamus, leads to impaired circadian rhythms and decreased melatonin production, which are thought to contribute to the syndrome Reimus2025Khachiyants2011Klaffke2006+1 MORE. Sleep disorders, mood disturbances, and disruptions in the sleep-wake cycle are also closely linked to sundowning Reimus2025Bliwise1993Klaffke2006+1 MORE. Environmental factors, such as changes in lighting, increased fatigue, and reduced social stimulation in the evening, may further exacerbate symptoms Canevelli2016Khachiyants2011Nazarko2011.
Clinical Correlates and Risk Factors
Sundowning is more likely to occur in older patients with later onset of dementia, more severe cognitive and functional impairment, frequent nocturnal awakenings, and hearing loss . The use of certain medications, such as anticholinergics and antipsychotics, is associated with a higher risk of sundowning, while the use of memantine appears to be protective . Seasonal variations, with greater agitation observed during winter, suggest a role for circadian timing and environmental light exposure .
Diagnostic Challenges
There is no universally agreed-upon definition or standardized assessment tool for sundowning, which complicates diagnosis and research Canevelli2016Khachiyants2011. Sundowning can be difficult to distinguish from other causes of behavioral disturbances in dementia, such as delirium or sleep disorders Canevelli2016Reimus2025. A thorough clinical evaluation is necessary to identify the specific factors contributing to each patient’s symptoms Reimus2025Blasi2023.
Management and Treatment Approaches
Non-Pharmacological Interventions
Non-drug strategies are generally preferred and include behavioral and environmental modifications, such as bright light therapy, music therapy, aromatherapy, and structured daily routines Khachiyants2011Nazarko2011Blais2014+1 MORE. These interventions aim to stabilize circadian rhythms and reduce environmental triggers for agitation Blais2014Klaffke2006. Caregiver education and support are also crucial, as behavioral interventions require active involvement from caregivers Reimus2025Nazarko2011.
Pharmacological Treatments
Pharmacological options are limited and should be used cautiously due to potential side effects. Melatonin and antipsychotics have some supportive evidence for use, while cholinesterase inhibitors and NMDA receptor antagonists (such as memantine) may also be beneficial Khachiyants2011Blais2014Klaffke2006. Sedatives and benzodiazepines are generally not recommended due to safety concerns and limited efficacy Reimus2025Blais2014.
Impact on Patients and Caregivers
Sundowning is associated with adverse outcomes, including increased caregiver burden, faster cognitive decline, and higher rates of institutionalization Canevelli2016Khachiyants2011Nazarko2011. Addressing sundowning can improve patient well-being, reduce distress, and help delay the need for institutional care Khachiyants2011Nazarko2011.
Conclusion
Sundowning is a common and distressing syndrome in dementia, characterized by evening neuropsychiatric symptoms driven by a combination of neurobiological, environmental, and psychosocial factors. Effective management requires a multidimensional approach, prioritizing non-pharmacological interventions and careful assessment of individual risk factors. Further research is needed to develop standardized definitions, assessment tools, and targeted treatments for sundowning in dementia Canevelli2016Reimus2025Khachiyants2011.
Sources and full results
Most relevant research papers on this topic